Skip to content

Open or Keyhole Surgery Through the Chest for Newborn Babies: Effect on Blood Gases

Hypercapnia During Thoracoscopy or Open Surgery for Repair of Oesophageal Atresia With Tracheo-oesophageal Fistula or Congenital Diaphragmatic Hernia in Neonates: Pilot Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01467245
Acronym
CO2
Enrollment
20
Registered
2011-11-08
Start date
2009-08-31
Completion date
2013-08-31
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Diaphragmatic Hernia, Esophageal Atresia With Tracheo-esophageal Fistula

Keywords

Thoracoscopy, congenital diaphragmatic hernia, oesophageal atresia, hypercapnia, acidosis, cerebral oxygenation, neonates

Brief summary

This is a pilot randomised controlled trial comparing open versus thoracoscopic surgery for repair of oesophageal atresia with tracheo-oesophageal fistula or congenital diaphragmatic hernia in neonates. Thoracoscopic surgery involves insufflation of carbon dioxide into the thoracic cavity and may therefore cause hypercapnia and acidosis.

Interventions

PROCEDUREHypercapnia during thoracoscopy

keyhole surgery through the chest for repair of oesophageal atresia with tracheo-oesophageal fistula or congenital diaphragmatic hernia in neonates

PROCEDUREOpen surgery

open surgery for repair of oesophageal atresia with tracheo-oesophageal fistula or congenital diaphragmatic hernia in neonates

Sponsors

Great Ormond Street Hospital for Children NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Months
Healthy volunteers
No

Inclusion criteria

* Neonates with diagnosis of oesophageal atresia with tracheo-oesophageal fistula or congenital diaphragmatic hernia -\>1.6 Kg * Conventional ventilation (no high frequency ventilation or iNO) for at least 24 hours. * FiO2 \<0.4 * No requirement for inotropes for at least 24 hours

Exclusion criteria

* Late diagnosis (after 1 month of age) * Major congenital heart defects or pulmonary hypertension * Bilateral grade IV intraventricular haemorrhage * Previous ECMO * FiO2 ≥ 0.4

Design outcomes

Primary

MeasureTime frameDescription
Arterial blood carbon dioxide measurementIntra-operativeArterial blood carbon dioxide will be measured during operation as standard of practice by obtaining the blood samples

Secondary

MeasureTime frameDescription
oxygenation of the brainIntra-operative and 24 hours post-operativelyoxygenation of the brain will be measured by a non-invasive technique, near infra-red spectroscopy

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026